Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Journal of Patient-Reported Outcomes
|
August 8, 2024
The symptoms evolution of long COVID‑19 (SE-LC19): a new patient-reported content valid instrument
Diana Rofail, Selin Somersan-Karakaya, Eleftherios Mylonakis, et al.
European Journal of Medicinal Chemistry
|
February 22, 2014
Benzimidazole-based compounds kill Mycobacterium tuberculosis
Yaling Gong, Selin Somersan Karakaya, Xiaoyong Guo, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 1, 2017
Rifamycin action on RNA polymerase in antibiotic-tolerant <i>Mycobacterium tuberculosis</i> results in differentially detectable populations
Kohta Saito, Thulasi Warrier, Selin Somersan-Karakaya, et al.
Mbio
|
October 18, 2022
Casirivimab and Imdevimab Treatment Reduces Viral Load and Improves Clinical Outcomes in Seropositive Hospitalized COVID-19 Patients with Nonneutralizing or Borderline Neutralizing Antibodies
Andrea T Hooper, Selin Somersan-Karakaya, Shane E McCarthy, et al.
Journal of Medicinal Chemistry
|
May 5, 2016
Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis
Ben Gold, Robert Smith, Quyen Nguyen, et al.
Open Forum Infectious Diseases
|
May 25, 2023
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial
Selin Somersan-Karakaya, Eleftherios Mylonakis, Jenni Mou, et al.
ACS Infectious Diseases
|
September 14, 2016
Identification of Novel Anti-mycobacterial Compounds by Screening a Pharmaceutical Small-Molecule Library against Nonreplicating Mycobacterium tuberculosis
Thulasi Warrier, Maria Martinez-Hoyos, Manuel Marin-Amieva, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 27, 2012
Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials
Ben Gold, Maneesh Pingle, Steven J Brickner, et al.
ACS Infectious Diseases
|
February 22, 2018
Identification of a Mycothiol-Dependent Nitroreductase from Mycobacterium tuberculosis
Ana Negri, Prisca Javidnia, Ran Mu, et al.
Ebiomedicine
|
September 13, 2024
Potential immunomodulatory effects of CAS+IMD monoclonal antibody cocktail in hospitalized patients with COVID-19
Bei Wang, Jacquelynn Golubov, Erin M Oswald, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Journal of Patient-Reported Outcomes
|
August 8, 2024
The symptoms evolution of long COVID‑19 (SE-LC19): a new patient-reported content valid instrument
Diana Rofail, Selin Somersan-Karakaya, Eleftherios Mylonakis, et al.
European Journal of Medicinal Chemistry
|
February 22, 2014
Benzimidazole-based compounds kill Mycobacterium tuberculosis
Yaling Gong, Selin Somersan Karakaya, Xiaoyong Guo, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 1, 2017
Rifamycin action on RNA polymerase in antibiotic-tolerant <i>Mycobacterium tuberculosis</i> results in differentially detectable populations
Kohta Saito, Thulasi Warrier, Selin Somersan-Karakaya, et al.
Mbio
|
October 18, 2022
Casirivimab and Imdevimab Treatment Reduces Viral Load and Improves Clinical Outcomes in Seropositive Hospitalized COVID-19 Patients with Nonneutralizing or Borderline Neutralizing Antibodies
Andrea T Hooper, Selin Somersan-Karakaya, Shane E McCarthy, et al.
Journal of Medicinal Chemistry
|
May 5, 2016
Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis
Ben Gold, Robert Smith, Quyen Nguyen, et al.
Open Forum Infectious Diseases
|
May 25, 2023
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial
Selin Somersan-Karakaya, Eleftherios Mylonakis, Jenni Mou, et al.
ACS Infectious Diseases
|
September 14, 2016
Identification of Novel Anti-mycobacterial Compounds by Screening a Pharmaceutical Small-Molecule Library against Nonreplicating Mycobacterium tuberculosis
Thulasi Warrier, Maria Martinez-Hoyos, Manuel Marin-Amieva, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 27, 2012
Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials
Ben Gold, Maneesh Pingle, Steven J Brickner, et al.
ACS Infectious Diseases
|
February 22, 2018
Identification of a Mycothiol-Dependent Nitroreductase from Mycobacterium tuberculosis
Ana Negri, Prisca Javidnia, Ran Mu, et al.
Ebiomedicine
|
September 13, 2024
Potential immunomodulatory effects of CAS+IMD monoclonal antibody cocktail in hospitalized patients with COVID-19
Bei Wang, Jacquelynn Golubov, Erin M Oswald, et al.
Page
of 3